Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-25 @ 2:41 PM
Study NCT ID:
NCT03573050
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2018-05-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
Sponsor:
SocraTec R&D GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-22
First Submit QC Date:
None
Study First Post Date:
2018-06-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-20
Last Update Post Date:
2018-08-21
Last Update Post Date Type:
ACTUAL